Abstract
The anti-tumor-promoting activity of 1’-acetoxychavicol acetate (ACA) was examined in a two-stage carcinogenesis experiment in ICR mouse skin using 7,12-dimethylbenz[a]anthracene (0.19 μmol) and 12-O-tetradecanoylphorbol-13-acetate (TPA; 1.6 nmol). Topical application of ACA (160 nmol) markedly reduced the average number of tumors per mouse and the ratio of tumor-bearing mice: inhibition ratios 90% (p < 0.001) and 42% (p < 0.005), respectively. ACA even at a dose equimolar to TPA (1.6 nmol) significantly reduced theaverage number of tumors per mouse: inhibitory ratio 44% (p < 0.05). ACA potently inhibited TPA-induced superoxide (O2) generation in differentiated HL-60 cells (IC50 = 4.3μM) and suppressed the lipid hydroperoxide formation by42% (p < 0.001) in the ethyl linoleate autoxidation test.
Original language | English |
---|---|
Pages (from-to) | 386-391 |
Number of pages | 6 |
Journal | Oncology (Switzerland) |
Volume | 53 |
Issue number | 5 |
DOIs | |
Publication status | Published - Jan 1 1996 |
Externally published | Yes |
Keywords
- 1’prime;-Acetoxychavicol acetate
- Antioxidant
- Antitumor promoter
- Cancer chemoprevention
- HL-60 cells
- Languas galanga
- Mouse skin
- Superoxide anion
- Xanthine oxidase
ASJC Scopus subject areas
- Oncology
- Cancer Research